Amicus Therapeutics Inc (FOLD)
10.10
-0.28
(-2.70%)
USD |
NASDAQ |
Nov 14, 16:00
10.10
0.00 (0.00%)
After-Hours: 18:02
Amicus Therapeutics Cash from Operations (Quarterly): -22.97M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -22.97M |
| June 30, 2024 | 22.69M |
| March 31, 2024 | -29.70M |
| December 31, 2023 | 3.458M |
| September 30, 2023 | -38.35M |
| June 30, 2023 | -16.13M |
| March 31, 2023 | -18.07M |
| December 31, 2022 | -80.77M |
| September 30, 2022 | -11.63M |
| June 30, 2022 | -15.86M |
| March 31, 2022 | -58.32M |
| December 31, 2021 | -70.51M |
| September 30, 2021 | -23.70M |
| June 30, 2021 | -35.92M |
| March 31, 2021 | -72.35M |
| December 31, 2020 | -49.82M |
| September 30, 2020 | -42.01M |
| June 30, 2020 | -33.52M |
| March 31, 2020 | -107.94M |
| December 31, 2019 | -57.83M |
| September 30, 2019 | -55.55M |
| June 30, 2019 | -58.48M |
| March 31, 2019 | -78.55M |
| December 31, 2018 | -60.68M |
| September 30, 2018 | -132.76M |
| Date | Value |
|---|---|
| June 30, 2018 | -57.00M |
| March 31, 2018 | -49.52M |
| December 31, 2017 | -73.03M |
| September 30, 2017 | -48.90M |
| June 30, 2017 | -41.91M |
| March 31, 2017 | -49.84M |
| December 31, 2016 | -31.60M |
| September 30, 2016 | -40.88M |
| June 30, 2016 | -32.74M |
| March 31, 2016 | -44.94M |
| December 31, 2015 | -35.51M |
| September 30, 2015 | -21.02M |
| June 30, 2015 | -22.64M |
| March 31, 2015 | -20.98M |
| December 31, 2014 | -14.51M |
| September 30, 2014 | -15.12M |
| June 30, 2014 | -11.82M |
| March 31, 2014 | -10.22M |
| December 31, 2013 | -8.12M |
| September 30, 2013 | -13.51M |
| June 30, 2013 | -10.26M |
| March 31, 2013 | -13.90M |
| December 31, 2012 | -7.374M |
| September 30, 2012 | -7.20M |
| June 30, 2012 | -11.13M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-107.94M
Minimum
Mar 2020
22.69M
Maximum
Jun 2024
-37.96M
Average
-34.72M
Median
Cash from Operations (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -9.919M |
| Alnylam Pharmaceuticals Inc | 43.71M |
| Ionis Pharmaceuticals Inc | -114.99M |
| Arbutus Biopharma Corp | -20.74M |
| Krystal Biotech Inc | 58.86M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 34.27M |
| Cash from Financing (Quarterly) | 18.19M |
| Free Cash Flow | -31.51M |
| Free Cash Flow Per Share (Quarterly) | -0.0766 |
| Free Cash Flow to Equity (Quarterly) | -23.88M |
| Free Cash Flow to Firm (Quarterly) | -34.84M |
| Free Cash Flow Yield | -1.03% |